Conversion Price Adjustment Due to Stock Consolidation
- 1st CB: conversion price from KRW 886 to 4,430; convertible shares from 4,514,672 to 902,934
- 2nd CB: conversion price from KRW 924 to 4,620; convertible shares from 2,164,502 to 432,900
- Reason: stock consolidation (5→1, effective date 2026-04-25)
- Adjustment applied automatically per bond terms; no separate board resolution
ADVERTISEMENT (250px+)
KOSDAQ Filing Information
- Filing: Adjustment of Conversion Price (1st Series, 2nd Series)
- Company: Poongjeon Pharmacy (298060)
- Submission: Poongjeon Pharmacy Co., Ltd.
- Receipt: 04-27-2026
- Under KRX KOSDAQ Market Division